Use of Botulinum Toxin (BTX) for the Treatment of Peripheral Painful Traumatic Trigeminal Neuropathy (PPTTN)
Phase of Trial: Phase III
Latest Information Update: 25 Apr 2019
Price : $35 *
At a glance
- Drugs Botulinum-Toxin-A (Primary)
- Indications Trigeminal neuralgia
- Focus Therapeutic Use
- Acronyms TRIGTOX
- 23 Apr 2019 Planned End Date changed from 1 May 2023 to 1 Apr 2023.
- 23 Apr 2019 Planned primary completion date changed from 1 Oct 2022 to 1 Nov 2022.
- 23 Apr 2019 Status changed from not yet recruiting to recruiting.